GT Biopharma, Inc. Financial Ratios — GTBP Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-2,356.69	-2,913.24	-268.63	-4,538.94	-4,550.11	24,729.11	-113.35	-185.29	-299.65	-934.32	-306.7	-85.41	-49.26	-143.53	-459.62
Return on Capital (%)	- -	- -	- -	- -	- -	-13.76	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	-84.62	72.51	38.59	6.56	100	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	-15,019.23	-1,026.61	-214.95	-3,891.8	-33,055.56	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	-15,107.69	-1,027.49	-215.49	-3,927.87	-33,062.96	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	1,655.56	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-14,230.77	-1,538.3	-136.14	-38,532.79	-79,485.19	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	-14,230.77	-1,511.99	-136.14	-38,506.56	-79,374.07	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	-14,230.77	-1,511.99	-136.14	-38,506.56	-79,374.07	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.32
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	2	2	3	3	10	12	- -	11	13	26	- -	- -	- -	- -	- -
ST Debt	2	2	2	3	9	12	- -	11	13	26	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	1	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	-0.53	-0.54	-3.27	-1.41	-1.09	-1.32	- -	-0.5	-1.17	-3.89	- -	-0.01	- -	- -	- -
Net Debt/EBITDA	-0.5	-0.5	-3.22	-1.05	-1.09	-1.32	- -	-0.5	-1.15	-3.11	0.16	0.27	0.08	0.28	0.55
Total Debt/EBIT	-0.52	-0.54	-3.26	-1.4	-1.09	-1.32	- -	-0.5	-1.17	-3.89	- -	-0.01	- -	- -	- -
Net Debt/EBIT	-0.5	-0.5	-3.21	-1.05	-1.09	-1.32	- -	-0.5	-1.15	-3.11	0.16	0.27	0.08	0.28	0.55
EBITDA to Interest Expense	-7.02	-2.12	-0.66	-0.46	-0.52	-1.43	-15.76	-2.36	-5.38	-2.04	-80.1	-2,657.12	-63.74	- -	-97.81
EBITDA-CapEx/Interest Expense	-7.02	-2.13	-0.66	-0.46	-0.52	-1.43	-15.76	-2.37	-5.38	-2.04	-80.1	-2,657.12	-63.74	- -	-97.81
EBIT to Interest Expense	-7.06	-2.13	-0.66	-0.47	-0.52	-1.43	-15.76	-2.36	-5.38	-2.04	-80.1	-2,657.12	-63.74	- -	-97.81
Interest Expense	1	2	1	5	17	7	9	9	2	3	1	- -	- -	- -	- -
Common Equity/Total Assets	-64,748.84	-39,143.81	-60,471.43	-12,720.05	-248,916.67	-498,596	-105.93	-2,081.32	-143,255.3	-10,524.5	-2,028.16	-4,029.85	-4,834.25	-16,427.81	-8,930.11
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.55	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	-0.11	-0.58	-0.57	- -	- -	- -	- -	- -	- -	-0.01	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	65.99	71.4	1,322.22	- -	- -	- -	- -	- -	- -	0.38	- -	- -	- -
Total Debt/Equity (%)	-40.4	-29.67	-40.86	-11.36	-19.27	-65.59	0.01	95.02	-69.18	-89.47	0.14	1.48	0.78	- -	- -
Total Debt/Capital (%)	-2.53	-2.17	-2.99	-3.06	-7.81	-11.04	-0.01	-2.09	-2.41	-4.62	- -	-0.03	-0.01	- -	- -
Total Debt/Total Assets (%)	1,597.67	831.86	1,760.54	378.27	18,050	49,652	0.01	42.54	3,373.23	465.18	0.1	1.04	0.41	- -	- -
Net Debt to Equity	-38.6	-27.73	-40.18	-8.47	-19.18	-65.49	-0.22	94.49	-68.41	-71.47	-40.79	-48.34	-14.43	236.59	-117.69
Net Debt/Capital (%)	-2.41	-2.02	-2.94	-2.26	-7.77	-11.02	0.2	-2.07	-2.38	-3.66	1.35	0.83	0.16	0.57	0.93
EBITDA	-4	-4	-1	-2	-9	-9	-136	-22	-11	-7	-58	-21	-14	-14	-12
EBITDA-CapEx	-4	-4	-1	-2	-9	-9	-136	-22	-11	-7	-58	-21	-14	-14	-12
Operating Income (Loss)	-4	-4	-1	-2	-9	-9	-136	-22	-11	-7	-58	-21	-14	-14	-12

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.02	0.02	0.01	0.03	- -	- -	0.22	- -	- -	0.15	3.12	3.34	2.11	0.67	2.94
Current Ratio	0.02	0.03	0.02	0.03	- -	- -	0.22	0.01	0.01	0.16	3.14	3.35	2.12	0.72	3.5
Quick Ratio	0.02	0.02	0.01	0.03	- -	- -	0.22	- -	- -	0.15	3.12	3.34	2.11	0.67	2.94
CFO/Avg Current Liab	-0.18	-0.17	-0.07	-0.1	-0.12	-0.06	-0.5	-1.28	-0.22	-0.27	-0.69	-2	-1.53	-2.06	-3.14
Common Equity/Total Assets	-64,748.84	-39,143.81	-60,471.43	-12,720.05	-248,916.67	-498,596	-105.93	-2,081.32	-143,255.3	-10,524.5	-2,028.16	-4,029.85	-4,834.25	-16,427.81	-8,930.11
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.55	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	-0.11	-0.58	-0.57	- -	- -	- -	- -	- -	- -	-0.01	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	65.99	71.4	1,322.22	- -	- -	- -	- -	- -	- -	0.38	- -	- -	- -
Total Debt/Equity (%)	-40.4	-29.67	-40.86	-11.36	-19.27	-65.59	0.01	95.02	-69.18	-89.47	0.14	1.48	0.78	- -	- -
Total Debt/Capital (%)	-2.53	-2.17	-2.99	-3.06	-7.81	-11.04	-0.01	-2.09	-2.41	-4.62	- -	-0.03	-0.01	- -	- -
Total Debt/Total Assets (%)	1,597.67	831.86	1,760.54	378.27	18,050	49,652	0.01	42.54	3,373.23	465.18	0.1	1.04	0.41	- -	- -
CFO/Total Liabilities	-18.41	-15.04	-6.82	-5.74	-9.2	-10.19	-202.69	-76.11	-18.57	-20.69	-152.12	-304.22	-133.45	-218.64	-556.88
CFO/CapEx	- -	-493.5	- -	-291.5	-4,657	- -	-1,357.5	-296.58	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	-1,311.54	-710.09	-1,080.11	-226.04	-5,137.92	-9,126.16	-1,382.95	-6,042.5	-2,160.07	-148.34	-28.5	-56.36	-69.29	-241.08	-128.11

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	18.4	3.05	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	19.84	119.67	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	8	2.65	4.48	2.71	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	45.62	137.85	81.56	134.47	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	0.08	0.17	0.23	0.02	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	4,352.62	2,179.65	1,587.49	16,449.33	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	-4,307	-2,041.8	-1,486.09	-16,195.19	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	-45.62	-137.85	-61.72	-14.8	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	3	75	33	- -	537	86	29	10	6	4
- Cash & Cash Equivalents	- -	- -	- -	1	- -	- -	1	- -	- -	5	9	6	1	4	7
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	2	2	3	3	10	12	- -	11	13	26	- -	- -	- -	- -	- -
Enterprise Value	2	2	2	2	10	15	74	43	13	558	54	12	-4	2	-2
Total Capital	-81	-87	-86	-110	-125	-112	-270	-518	-554	-570	-652	-674	-682	-695	-724
Total Debt/Capital (%)	-2.53	-2.17	-2.99	-3.06	-7.81	-11.04	-0.01	-2.09	-2.41	-4.62	- -	-0.03	-0.01	- -	- -
Total Debt / EV	1.05	1.13	1.08	1.44	1.02	0.82	- -	0.25	0.99	0.05	- -	0.01	-0.02	- -	- -
EV/Sales	75.85	4.88	6.51	38.33	353.11	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	2.51	3.18	0.69	0.77	3.29	23.3	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	2.5	3.18	0.69	0.77	3.29	23.27	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	3	75	33	- -	537	86	29	10	6	4
Diluted Enterprise Value	2	2	2	2	10	15	74	43	13	558	77	23	9	2	-2
EV per Share	281,714.29	128,461.54	171,071.43	155,866.67	635,600	74,622.98	2,247.85	438.87	2,025.33	224.64	57.46	11.35	- -	0.97	- -
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	-4	-4	-1	-2	-9	-9	-136	-22	-11	-7	-58	-21	-14	-14	-12
TTM Operating Income	-4	-4	-1	-2	-9	-9	-136	-22	-11	-7	-58	-21	-14	-14	-12
TTM Cash Flow to Firm	- -	1	1	3	12	5	3	-2	-2	-4	-15	-15	-9	-13	-13
TTM Free Cash Flow to Firm	- -	1	1	3	12	5	3	-2	-2	-4	-15	-15	-9	-13	-13

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	-1.55	-13.75	-3.07	-0.07	-73.99	-5.5	-1.87	-1.16	-0.45	-0.34
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	2	2	2	2	10	15	74	43	13	558	54	12	-4	2	-2
Low Price	- -	- -	- -	- -	- -	12,363.62	1,545.45	295.8	33.15	39.53	88.8	26.27	5.39	1.72	0.54
EV/Sales	75.85	4.88	6.51	38.33	353.11	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	0.31	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	0.76	-1.16	-0.37	-0.03	-7.99	-4.32	-3.73	-2.16	-0.5	-0.34
Price/Earnings High	- -	- -	- -	- -	- -	3.07	-9.24	-1.13	-0.08	-34.49	-9.58	-5.76	-5.85	-1.54	-0.74
Price/Earnings Low	- -	- -	- -	- -	- -	0.26	-0.35	-0.11	-0.01	-3.47	-1.44	-1.35	-0.96	-0.25	-0.1
Price/Book Value	- -	- -	- -	- -	- -	-0.02	-0.28	-0.06	- -	-0.9	-0.13	-0.04	-0.02	-0.01	-0.01
Price/Book Value Average	- -	- -	- -	- -	- -	-0.06	-0.62	-0.18	- -	-0.38	-0.38	-0.12	-0.02	-0.01	-0.01
Price/Book Value High	- -	- -	- -	- -	- -	-0.24	-4.95	-0.56	-0.01	-1.64	-0.85	-0.18	-0.07	-0.03	-0.03
Price/Book Value Low	- -	- -	- -	- -	- -	-0.02	-0.19	-0.06	- -	-0.16	-0.13	-0.04	-0.01	- -	- -
Price/Tangible Book Value	- -	- -	- -	- -	- -	-0.16	-35.7	-2.35	-0.01	-18.25	3.92	2.43	1.38	-3.46	0.75
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	-0.39	-79.73	-6.94	-0.05	-7.68	11.45	6.63	2.2	-3.94	1.69
Price/Tangible Book Value High	- -	- -	- -	- -	- -	-1.58	-637.73	-21.15	-0.17	-33.15	25.36	10.26	5.95	-12.1	3.67
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	-0.13	-24.31	-2.1	-0.01	-3.34	3.8	2.4	0.97	-1.95	0.51
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	- -	- -	-1.55	-13.74	-3.06	-0.07	-73.99	-5.5	-1.87	-1.16	-0.45	-0.34
Price/Cash Flow Average	- -	- -	- -	- -	- -	-3.83	-30.69	-9.03	-0.27	-31.13	-16.08	-5.12	-1.85	-0.51	-0.76
Price/Cash Flow High	- -	- -	- -	- -	- -	-15.52	-245.46	-27.53	-0.89	-134.38	-35.6	-7.91	-5.02	-1.57	-1.64
Price/Cash Flow Low	- -	- -	- -	- -	- -	-1.31	-9.36	-2.73	-0.06	-13.53	-5.34	-1.85	-0.82	-0.25	-0.23
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	-3.83	-30.71	-9.06	-0.27	-31.13	-16.08	-5.12	-1.85	-0.51	-0.76
Price/Free Cash Flow High	- -	- -	- -	- -	- -	-15.52	-245.64	-27.62	-0.89	-134.38	-35.6	-7.91	-5.02	-1.57	-1.64
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	-1.31	-9.36	-2.74	-0.06	-13.53	-5.34	-1.85	-0.82	-0.25	-0.23
EV/Sales Average	75.85	4.88	6.51	38.33	353.11	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	75.85	4.88	6.51	38.33	353.11	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	75.85	4.88	6.51	38.33	353.11	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	-0.5	-0.48	-3.03	-0.98	-1.07	-2.09	-1.22	-4.96	-1.24	-36.51	-4.21	-3.4	-1.13	-0.18	-0.24
EV/EBITDA High	-0.5	-0.48	-3.03	-0.98	-1.07	-4.5	-9.83	-14.13	-1.43	-147.35	-9.5	-5.4	-3.2	-1.13	-1.16
EV/EBITDA Low	-0.5	-0.48	-3.03	-0.98	-1.07	-1.57	-0.37	-1.84	-1.17	-17.61	-1.29	-1.07	-0.46	0.05	0.31
EV/EBIT Average	-0.5	-0.48	-3.02	-0.98	-1.07	-2.09	-1.22	-4.96	-1.24	-36.51	-4.21	-3.4	-1.13	-0.18	-0.24
EV/EBIT High	-0.5	-0.48	-3.02	-0.98	-1.07	-4.5	-9.83	-14.13	-1.43	-147.35	-9.5	-5.4	-3.2	-1.13	-1.16
EV/EBIT Low	-0.5	-0.48	-3.02	-0.98	-1.07	-1.57	-0.37	-1.84	-1.17	-17.61	-1.29	-1.07	-0.46	0.05	0.31
Last Price	- -	- -	- -	- -	- -	14,681.8	2,269.5	331.5	41.31	216.24	91.5	26.57	7.65	3.05	0.79
High Price	- -	- -	- -	- -	- -	146,818.04	40,537.23	2,983.5	492.15	392.7	591.99	112.2	33	10.66	3.85
Enterprise Value Average	2	2	2	2	10	20	166	107	14	247	242	72	15	3	3
Enterprise Value High	2	2	2	2	10	42	1,332	304	16	997	547	115	43	16	14
Enterprise Value Low	2	2	2	2	10	15	50	40	13	119	74	23	6	-1	-4

Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	2	26
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	1	1	1	2	6
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	1	1	1	2	6
Revenue per Share	3,714.29	26,307.69	26,285.71	4,066.67	1,800	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-557,857.14	-270,076.92	-56,500	-158,266.67	-595,000	-45,946.08	-4,123.11	-218.73	-1,726.15	-2.72	-61.28	-19.81	-10.07	-7.57	-2.25
Operating Income per Share	-561,142.86	-270,307.69	-56,642.86	-159,733.33	-595,133.33	-45,950.98	-4,123.18	-218.8	-1,726.75	-2.72	-61.28	-19.81	-10.07	-7.57	-2.25
Basic EPS, GAAP	-528,571.43	-397,769.23	-35,785.71	-1,565,933.33	-1,428,733.33	47,882.35	-4,384.79	-2,631.06	-5,824.72	-11.39	-61.81	-19.46	-5.64	-6.94	-5.2
Basic EPS from Cont Ops	-528,571.43	-404,692.31	-35,785.71	-1,567,000	-1,430,733.33	47,882.35	-4,384.79	-2,631.06	-5,824.72	-11.39	-61.81	-19.46	-5.64	-6.94	-5.14
Diluted EPS, GAAP	-528,571.43	-397,769.23	-35,785.71	-1,565,933.33	-1,428,733.33	47,882.35	-4,384.79	-2,631.06	-5,824.72	-11.39	-61.81	-19.46	-5.64	-6.94	-5.2
Diluted EPS from Cont Ops	-528,571.43	-404,692.31	-35,785.71	-1,567,000	-1,430,733.33	47,882.35	-4,384.79	-2,631.06	-5,824.72	-11.39	-61.81	-19.46	-5.64	-6.94	-5.14
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.04
Cash Flow per Share	-137,571.43	-75,923.08	-31,571.43	-116,600	-310,466.67	-9,460.78	-165.15	-108.38	-551.47	-2.92	-16.63	-14.18	-6.57	-6.8	-2.34
Free Cash Flow per Basic Share	-137,571.43	-76,076.92	-31,571.43	-117,000	-310,533.33	-9,460.78	-165.27	-108.75	-551.47	-2.92	-16.63	-14.18	-6.57	-6.8	-2.34
Cash & Equivalents per Share	13,142.86	9,461.54	3,071.43	57,000	3,133.33	93.14	17.52	0.61	4.22	2.13	34.07	15.38	10.37	2.08	1.24
Book Value per Share	-11,932,285.71	-6,805,000	-6,349,500	-7,530,266.67	-8,961,000	-611,024.51	-8,194.92	-5,366.3	-85,499.77	-239.76	-695.18	-628.55	-506.09	-366.41	-131.3
Tangible Book Value per Share	-732,714.29	-489,461.54	-454,214.29	-1,971,800	-3,371,466.67	-92,779.41	-63.56	-141.04	-2,910.78	-11.85	23.34	10.93	5.55	-0.88	1.05

GT Biopharma, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)